CDX2 is a caudal-type homeobox, intestine-specific transcription factor expressed early in intestinal development and may be involved in the regulation of proliferation and differentiation of intestinal epithelial cells. CDX2, as well as CDX1, is of particular interest as the intestine is the only organ that contains detectable levels of either gene product.
This pattern of restricted expression is unusual for homeobox genes. Phosphorylation of the CDX2 activation domain can modulate its function and different spatial expression patterns in the intestinal epithelium. CDX2 is primarily expressed on the surface of the villus and in the crypts. In contrast to CDX1, intense CDX2 expression is reported to occur in all but the distal portions of the developing intestine.
The loss of CDX2 has been reported to contribute towards the progression of some sporadic colorectal cancers. It has been reported that CDX2 may also be associated with carcinogenesis of the stomach as expression of CDX2 mRNA progressively decreases with the transition from well differentiated to poorly differentiated gastric cancer cell lines.
|PA0535||7ml CDX2 Bond RTU Primary||Bond ready to use reagent||P(HIER)||Info||MSDS||1|
|CDX2-L-U||1ml NCL-L-CDX2||Liquid Concentrated Monoclonal Antibody||P(HIER)||Info||MSDS||1|
|CDX2||1ml NCL-CDX2||Lyophilised Concentrated Monoclonal Antibody||P(HIER)||Info||1|
|CDX2-U||1ml NCL-CDX2 US IVD||Lyophilised Concentrated Monoclonal Antibody||P(HIER)||MSDS||1|
|CDX2-S||0.1ml NCL-CDX2||Lyophilised Concentrated Monoclonal Antibody||P(HIER)||Info||MSDS||1|
|PA0375||7ml CDX2 (EP25) Bond RTU Primary||Bond ready to use reagent||P(HIER)||Info||MSDS||1|